Biblio
“INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.”, J Alzheimers Dis, vol. 58, no. 3, pp. 687-694, 2017.
, “Urinary Amino Acid-Conjugated Acrolein and Taurine as New Biomarkers for Detection of Dementia.”, J Alzheimers Dis, vol. 92, no. 1, pp. 361-369, 2023.
, “Tau and Amyloid-β Pathology in Japanese Forensic Autopsy Series Under 40 Years of Age: Prevalence and Association with APOE Genotype and Suicide Risk.”, J Alzheimers Dis, vol. 72, no. 2, pp. 641-652, 2019.
, “Situation Model for Situation-Aware Assistance of Dementia Patients in Outdoor Mobility.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1461-1476, 2017.
, “Predictive factors for disease progression in patients with early-onset Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 85-91, 2016.
, “Differences in Depressive Patterns According to Disease Severityin Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 91-9, 2016.
, “Anti-Inflammatory Gene Therapy Improves Spatial Memory Performance in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1001-1008, 2022.
, “The Korean Size/Weight Attribute Test: A Semantic Knowledge Test for Korean Older Adults and Brain-Imaging Evidence.”, J Alzheimers Dis, vol. 49, no. 2, pp. 377-86, 2016.
, “Altered Topology in Information Processing of a Narrated Story in Older Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 2, pp. 517-33, 2016.
, “SIRT1 Deacetylates SC35 and Suppresses Its Function in Tau Exon 10 Inclusion.”, J Alzheimers Dis, vol. 61, no. 2, pp. 561-570, 2018.
, “Autophagy-ERK1/2-Involved Disinhibition of Hippocampal Neurons Contributes to the Pre-Synaptic Toxicity Induced by Aβ42 Exposure.”, J Alzheimers Dis, vol. 59, no. 3, pp. 851-869, 2017.
, “Changes in Synaptic Plasticity and Glutamate Receptors in Type 2 Diabetic KK-Ay Mice.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1207-1220, 2017.
, “A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1381-1392, 2020.
, “Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.”, J Alzheimers Dis, vol. 58, no. 2, pp. 355-359, 2017.
, “Effectiveness of a Personalized Brain-Computer Interface System for Cognitive Training in Healthy Elderly: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 66, no. 1, pp. 127-138, 2018.
, “BACE2: A Promising Neuroprotective Candidate for Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S159-S171, 2023.
, “Posterior Ventricular Enlargement to Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1237-43, 2016.
, “Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 49, no. 2, pp. 483-91, 2016.
, “Shared Genetic Risk Factors for Late-Life Depression and Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 1-15, 2016.
, “Investigating the efficacy of ergothioneine to delay cognitive decline in mild cognitively impaired subjects: A pilot study.”, J Alzheimers Dis, vol. 102, no. 3, pp. 841-854, 2024.
, “What is the Relationship between Health, Mood, and Mild Cognitive Impairment?”, J Alzheimers Dis, vol. 55, no. 3, pp. 1183-1193, 2017.
, “Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators.”, J Alzheimers Dis, vol. 50, no. 3, pp. 733-40, 2016.
, “Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 3, pp. 897-907, 2020.
, “Associations of Angiotensin Converting Enzyme-1 and Angiotensin II Blood Levels and Cognitive Function.”, J Alzheimers Dis, vol. 63, no. 2, pp. 655-664, 2018.
, “Angiotensin II Blood Levels Are Associated with Smaller Hippocampal and Cortical Volumes in Cognitively Normal Older Adults.”, J Alzheimers Dis, vol. 75, no. 2, pp. 521-529, 2020.
,